453
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Glycemic control after addition of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes showing inadequate response to thrice-a-day treatment with α-glucosidase inhibitors

, , , , , , , , , , , , , , & , MD, PhD show all
Pages 1111-1118 | Published online: 22 Apr 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sanjay Kalra. (2014) Incretin enhancement without hyperinsulinemia: α-glucosidase inhibitors. Expert Review of Endocrinology & Metabolism 9:5, pages 423-425.
Read now
Yutaka Seino & Daisuke Yabe. (2014) Alogliptin benzoate for the treatment of type 2 diabetes. Expert Opinion on Pharmacotherapy 15:6, pages 851-863.
Read now

Articles from other publishers (3)

Hae Kyung Yang, Seung-Hwan LeeJuyoung ShinYoon-Hee ChoiYu-Bae AhnByung-Wan LeeEun Jung RheeKyung Wan MinKun-Ho Yoon. (2019) Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. Diabetes & Metabolism Journal 43:3, pages 287.
Crossref
Mitsuyoshi Takahara, Toshihiko Shiraiwa, Naoto Katakami, Hideaki Kaneto, Taka-aki Matsuoka & Iichiro Shimomura. (2014) Efficacy of adding once- and thrice-daily voglibose in Japanese type 2 diabetic patients treated with alogliptin. Endocrine Journal 61:5, pages 447-456.
Crossref
Kazutaka Aoki, Hiroshi Kamiyama, Kiyomi Masuda, Kazunari Kamiko, Yoshihiko Noguchi, Kazuki Tajima & Yasuo Terauchi. (2014) Effects of miglitol, vildagliptin, or their combination on serum insulin and peptide YY levels and plasma glucose, cholecystokinin, ghrelin, and obestatin levels. Endocrine Journal 61:3, pages 249-256.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.